logo

Tscan Therapeutics Inc (TCRX) Stock: A Comprehensive 52-Week Review

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Tscan Therapeutics Inc’s current trading price is 1.91% away from its 52-week high, while its distance from the 52-week low is 395.06%. The stock’s price range over this period has fluctuated between $1.62 and $7.87. The company, operating within the financial sector, had a trading volume of approximately 0.53 million for the day, which was noticeably higher than the average daily share volume of 0.15 million over the last 3 months.

In terms of market performance, Tscan Therapeutics Inc had a fairly even. The highest value for the stock in the past year was $7.87 on 03/22/24, and the lowest value was recorded at $1.62 on 05/01/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Tscan Therapeutics Inc (TCRX) has experienced a quarterly rise of 65.70% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 349.75M and boasts a workforce of 154 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 5.75, with a change in price of +4.62. Similarly, Tscan Therapeutics Inc recorded 149,387 in trading volume during the last 100 days, posting a change of +135.88%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for TCRX stands at 0.61. Similarly, the long-term debt-to-equity ratio is also 0.57.

TCRX Stock Stochastic Average

Today’s raw stochastic average for Tscan Therapeutics Inc over the last 50 days is 98.87%.This indicates a increase from the raw stochastic average of the past 20 days, which was 97.97%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 70.38% and 58.70%, respectively.

TCRX Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price increase of 37.56%. However, over the past six months, we’ve seen a weaker performance of 202.64%. The price of TCRX fallen by 17.60% over the last 30 days. And in the last five days, it has surged by 12.64%.

Most Popular